🚀 VC round data is live in beta, check it out!
Medclair Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medclair and similar public comparables like AnteoTech, Impedimed, Cambridge Cognition, Pulsenmore and more.
Medclair Overview
About Medclair
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
Founded
2013
HQ
Employees
14
Website
Sectors
Financials (FY)
EV
$23M
Medclair Financials
Medclair reported last fiscal year revenue of $6M and EBITDA of $1M.
In the same fiscal year, Medclair generated $4M in gross profit, $1M in EBITDA, and $508K in net income.
Medclair P&L
In the most recent fiscal year, Medclair reported revenue of $6M and EBITDA of $1M.
Medclair expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $6M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $4M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 73% | XXX | XXX | XXX |
| EBITDA | — | XXX | $1M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 12% | XXX | XXX | XXX |
| Net Profit | — | XXX | $508K | XXX | XXX | XXX |
| Net Margin | — | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medclair Stock Performance
Medclair has current market cap of $24M, and enterprise value of $23M.
Market Cap Evolution
Medclair's stock price is $0.26.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $23M | $24M | 0.3% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedclair Valuation Multiples
Medclair trades at 4.1x EV/Revenue multiple, and 20.9x EV/EBITDA.
Medclair Financial Valuation Multiples
As of April 20, 2026, Medclair has market cap of $24M and EV of $23M.
Equity research analysts estimate Medclair's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medclair has a P/E ratio of 46.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24M | XXX | $24M | XXX | XXX | XXX |
| EV (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 20.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 34.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.6x | XXX | XXX | XXX |
| P/E | — | XXX | 46.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 101.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medclair Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medclair Margins & Growth Rates
Medclair's revenue in the last fiscal year grew by 62%.
Medclair's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Medclair Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 62% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 112% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 61% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medclair Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medclair | XXX | XXX | XXX | XXX | XXX | XXX |
| AnteoTech | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Cambridge Cognition | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulsenmore | XXX | XXX | XXX | XXX | XXX | XXX |
| Integrum | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medclair M&A Activity
Medclair acquired XXX companies to date.
Last acquisition by Medclair was on XXXXXXXX, XXXXX. Medclair acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medclair
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedclair Investment Activity
Medclair invested in XXX companies to date.
Medclair made its latest investment on XXXXXXXX, XXXXX. Medclair invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medclair
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medclair
| When was Medclair founded? | Medclair was founded in 2013. |
| Where is Medclair headquartered? | Medclair is headquartered in Sweden. |
| How many employees does Medclair have? | As of today, Medclair has over 14 employees. |
| Is Medclair publicly listed? | Yes, Medclair is a public company listed on Nasdaq Global Market. |
| What is the stock symbol of Medclair? | Medclair trades under MCLR ticker. |
| When did Medclair go public? | Medclair went public in 2017. |
| Who are competitors of Medclair? | Medclair main competitors are AnteoTech, Impedimed, Cambridge Cognition, Pulsenmore. |
| What is the current market cap of Medclair? | Medclair's current market cap is $24M. |
| What is the current revenue of Medclair? | Medclair's last fiscal year revenue is $6M. |
| What is the current EV/Revenue multiple of Medclair? | Current revenue multiple of Medclair is 4.1x. |
| Is Medclair profitable? | No, Medclair is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.